利多卡因治疗苯海拉明诱导的室性心动过速:一例病例报告
本文报告一例16岁女性摄入约315片苯海拉明后,在急诊科复苏期间出现无脉性室性心动过速。经碳酸氢钠、胺碘酮和除颤后恢复自主循环,但随后不久复发宽QRS波心动过速。给予利多卡因推注及持续输注后,QRS波逐渐变窄、节律稳定。毒理学检测确认苯海拉明暴露,利多卡因输注逐渐减停,患者出院回家,未再出现心律失常。体外实验数据显示苯海拉明优先与开放状态的钠通道结合且解离缓慢,提示利多卡因治疗效应的机制基础。
要点
- 苯海拉明过量可通过钠通道阻滞导致危及生命的室性心律失常,类似三环类抗抑郁药(TCA)毒性。
- 当前管理指南推荐碳酸氢钠作为一线治疗,难治性病例可考虑利多卡因等Ib类抗心律失常药,但该推荐主要从TCA数据外推。
- 16岁女性摄入约315片苯海拉明后出现无脉性室速,经碳酸氢钠、胺碘酮和除颤后恢复自主循环。
- 随后复发宽QRS波心动过速,给予利多卡因推注及持续输注后QRS波逐渐变窄、节律稳定。
- 本病例为利多卡因作为苯海拉明诱导钠通道阻滞所致难治性室性心律失常辅助治疗提供了额外临床证据,并强调严重抗组胺药中毒时早期识别和咨询中毒中心的重要性。
适用人群与场景
- 苯海拉明过量导致钠通道阻滞相关室性心律失常的患者,如本病例中摄入约315片苯海拉明的16岁女性。
处置流程与药物剂量
- 当前管理指南推荐碳酸氢钠作为苯海拉明过量所致钠通道阻滞相关室性心律失常的一线治疗。
- 难治性病例可考虑利多卡因等Ib类抗心律失常药,但该推荐主要从TCA数据外推。
- 本病例中,无脉性室速经碳酸氢钠、胺碘酮和除颤后恢复自主循环;复发宽QRS波心动过速后给予利多卡因推注及持续输注,随后QRS波逐渐变窄、节律稳定,利多卡因输注逐渐减停。
红旗征与不能漏的情况
- 苯海拉明过量可导致无脉性室性心动过速等危及生命的室性心律失常。
- 严重抗组胺药中毒需早期识别并咨询中毒中心。
研究设计与关键结果
- 病例报告:16岁女性摄入约315片苯海拉明后,在急诊科复苏期间出现无脉性室性心动过速。
- 经碳酸氢钠、胺碘酮和除颤后恢复自主循环,但随后不久复发宽QRS波心动过速。
- 给予利多卡因推注及持续输注后,QRS波逐渐变窄、节律稳定;毒理学检测确认苯海拉明暴露;利多卡因输注逐渐减停,患者出院回家,未再出现心律失常。
- 体外实验数据显示苯海拉明优先与开放状态的钠通道结合且解离缓慢,提示利多卡因治疗效应的机制基础。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本病例提示,对苯海拉明诱导钠通道阻滞所致难治性室性心律失常,利多卡因可作为辅助治疗;作者认为这为利多卡因的使用提供了额外临床证据,并强调严重抗组胺药中毒时早期识别和咨询中毒中心的重要性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Diphenhydramine overdose can cause life-threatening ventricular dysrhythmias through sodium channel blockade, similar to tricyclic antidepressant (TCA) toxicity. Current management guidelines recommend sodium bicarbonate as first-line therapy, with class Ib antiarrhythmics such as lidocaine considered in refractory cases, though this recommendation is largely extrapolated from TCA data. Clinical reports describing lidocaine use in diphenhydramine toxicity remain exceedingly rare. We report a case where a 16-year-old female who ingested approximately 315 tablets of diphenhydramine and developed pulseless ventricular tachycardia during emergency department resuscitation. Return of spontaneous circulation was achieved after sodium bicarbonate, amiodarone and defibrillation, but recurrent wide-complex tachycardia occurred shortly thereafter. She was treated with a lidocaine bolus and continuous infusion, resulting in progressive QRS narrowing and rhythm stabilization. Diphenhydramine exposure was confirmed with toxicology testing. The lidocaine infusion was weaned, and patient was discharged home without further dysrhythmias. Experimental data demonstrates that diphenhydramine binds preferentially to open sodium channels and dissociates slowly, suggesting a mechanistic basis for lidocaine's therapeutic effect. This case provides additional clinical evidence supporting the use of lidocaine as an adjunct for refractory ventricular dysrhythmias in diphenhydramine induced sodium channel blockade and highlights the important of early recognition and consultation with a poison center in severe antihistamine toxicity.
参考来源
- Carroll S, McGee M, Audette M, et al. Lidocaine for diphenhydramine-induced ventricular tachycardia: A case report. Am J Emerg Med. 2026. PMID: 41610479. doi:10.1016/j.ajem.2026.01.040
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。